• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

May1
XTL BioPharma released FY2024 Q4 earnings on April 30 (EST), actual revenue USD 405 K, actual EPS USD -0.0909
03:00
XTL BioPharma released FY2024 annual earnings on April 30 (EST), actual revenue USD 451 K, actual EPS USD -0.2999
03:00
Apr30
XTL Biopharma Reports $1.03M Net Loss in Fiscal Year 2024
20:02
Dec31
XTL BioPharma released FY2024 Q3 earnings on December 30 (EST) with actual revenue of 46 K USD and EPS of -0.1333 USD
04:00
XTL BioPharma released FY2024 Semi-Annual Earnings on December 30 (EST) with actual revenue of 0 USD and EPS of -0.0401 USD
04:00
XTL BioPharma released FY2024 9 Months Earnings on December 30 (EST), with actual revenue of 46K USD and EPS of -0.1844 USD
04:00

Schedules & Filings

Schedules
Filings
Apr30
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 405 K, Net Income -255 K, EPS -0.0909

Dec30
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 46 K, Net Income -553 K, EPS -0.1333

May13
Earning Release(EST)

FY2024 Q1 Earning Release (USD) Net Income 485 K, EPS 0.089

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More